Skip to main content

Table 1 Vancomycin clearance in continuous or chronic haemodialysis: data from the literature.

From: Clinical review: Use of vancomycin in haemodialysis patients

Reference

n

Dialysis

Membrane

CLHD (ml/min)

CLER (ml/min)

[13]

16

CAVHDF

PAN

6.9–15.4

ND

[14]

5

CVVH

AN

5.8–13.4

ND

[14]

5

CVVH

PMMA

7.5–27

ND

[14]

5

CVVH

PS

5.2–22.1

ND

[15]

12

HD

PS

76

ND

[15]

15

HD

PAN

55

ND

[15]*

8

HD

C

15

ND

[16]

5

HD

PS

130.7

ND

[17]*

6

HD

C

9.6

ND

[17]

6

HD

PS

44.7–85.2

ND

[18]

12

HD

PS

120

8.5

[19]

26

HD

CT, PS, PMMA

83

ND

[20]*

8

HD

C

9.7

5.2

[20]

8

HD

PAN

58.4

5.2

[21]

8

HD

PS

108.5

ND

[22]

6

HD

CT

49.2–111.4

ND

[23]

7

HD

PAN

45.7

<5

[23]

6

HD

CA

43.3

<5

  1. *Data from studies performed with cuprophan membranes. AN, acrylonitrile; C, cuprophan; CA, cellulose acetate; CAVH, continuous arteriovenous haemodialysis; CAVHDF, continuous arteriovenous haemodiafiltration; CLER, extrarenal clearance; CLHD, haemodialysis clearance; CT, cellulose triacetate; CVVH, continuous venovenous haemodialysis; HD, haemodialysis; ND, not determined; PA, polyamide; PAN, polyacrylonitrile; PMMA, polymethylmethacrylate; PS, polysulfone.